Adverse events966

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 966

Type	Event	Organ system	Group	Affected	At risk
other	pain in extremity	Musculoskeletal and connective tissue disorders	Part 1 Cohort 1(150mg)	3	6
other	pain in extremity	Musculoskeletal and connective tissue disorders	Part 1 Cohort 2 (200mg)	0	6
other	pain in extremity	Musculoskeletal and connective tissue disorders	Part 1 Cohort 3 (250mg)	2	6
other	pain in extremity	Musculoskeletal and connective tissue disorders	Part 2 (Double-blind Placebo Controlled) Placebo Arm	4	21
other	pain in extremity	Musculoskeletal and connective tissue disorders	Part 2 (Double-blind Placebo Controlled) ACE-083 Arm	6	23
other	pain in extremity	Musculoskeletal and connective tissue disorders	Part 2 (Open Label)	8	40
other	muscle spasm	Musculoskeletal and connective tissue disorders	Part 1 Cohort 1(150mg)	1	6
other	muscle spasm	Musculoskeletal and connective tissue disorders	Part 1 Cohort 2 (200mg)	2	6
other	muscle spasm	Musculoskeletal and connective tissue disorders	Part 1 Cohort 3 (250mg)	1	6
other	muscle spasm	Musculoskeletal and connective tissue disorders	Part 2 (Double-blind Placebo Controlled) Placebo Arm	1	21
other	muscle spasm	Musculoskeletal and connective tissue disorders	Part 2 (Double-blind Placebo Controlled) ACE-083 Arm	2	23
other	muscle spasm	Musculoskeletal and connective tissue disorders	Part 2 (Open Label)	1	40
other	myalgia	Musculoskeletal and connective tissue disorders	Part 1 Cohort 1(150mg)	1	6
other	myalgia	Musculoskeletal and connective tissue disorders	Part 1 Cohort 2 (200mg)	1	6
other	myalgia	Musculoskeletal and connective tissue disorders	Part 1 Cohort 3 (250mg)	1	6
other	myalgia	Musculoskeletal and connective tissue disorders	Part 2 (Double-blind Placebo Controlled) Placebo Arm	2	21
other	myalgia	Musculoskeletal and connective tissue disorders	Part 2 (Double-blind Placebo Controlled) ACE-083 Arm	7	23
other	myalgia	Musculoskeletal and connective tissue disorders	Part 2 (Open Label)	6	40
other	joint stiffness	Musculoskeletal and connective tissue disorders	Part 1 Cohort 1(150mg)	1	6
other	joint stiffness	Musculoskeletal and connective tissue disorders	Part 1 Cohort 2 (200mg)	0	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03124459/events

API reference For AI assistants

Adverse events966

Sources 3

Read this list from software.